CoChat

The Role of Bacteria in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis

Open access
Molyneaux, Phillip L., Cox, Michael J., Willis-Owen, Saffron A. G., Mallia, Patrick, Russell, Kirsty E., Russell, Anne-Marie, Murphy, Elissa, Johnston, Sebastian L., Schwartz, David A., Wells, Athol U., Cookson, William O. C., Maher, Toby M., Moffatt, Miriam F. · 2014 · American Journal of Respiratory and Critical Care Medicine

The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

Rationale: Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease of unknown cause that leads to respiratory failure and death within 5 years of diagnosis. Overt respiratory infection and immunosuppression carry a high morbidity and mortality, and polymorphisms in genes related to epithelial integrity and host defense predispose to IPF. Objectives: To investigate the role of bacteria in the pathogenesis and progression of IPF. Methods: We prospectively enrolled patients diagnosed with IPF according to international criteria together with healthy smokers, nonsmokers, and subjects with moderate chronic obstructive pulmonary disease as control subjects. Subjects underwent bronchoalveolar lavage (BAL), from which genomic DNA was isolated. The V3–V5 region of the bacterial 16S rRNA gene was amplified, allowing quantification of bacterial load and identification of communities by 16S rRNA quantitative polymerase chain reaction and pyrosequencing. Measurements and Main Results: Sixty-five patients with IPF had double the burden of bacteria in BAL fluid compared with 44 control subjects. Baseline bacterial burden predicted the rate of decline in lung volume and risk of death and associated independently with the rs35705950 polymorphism of the MUC5B mucin gene, a proven host susceptibility factor for IPF. Sequencing yielded 912,883 high-quality reads from all subjects. We identified Haemophilus, Streptococcus, Neisseria, and Veillonella spp. to be more abundant in cases than control subjects. Regression analyses indicated that these specific operational taxonomic units as well as bacterial burden associated independently with IPF. Conclusions: IPF is characterized by an increased bacterial burden in BAL that predicts decline in lung function and death. Trials of antimicrobial therapy are needed to determine if microbial burden is pathogenic in the disease.

Overview

Integrity signals

Registry

Crossref · 10.1164/rccm.201403-0541oc

Cites

43 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 44 references

Cited by

See all 578

Metadata

Authors
Molyneaux, P. L., Cox, M. J., Willis-Owen, S. A. G., Mallia, P., Russell, K. E., Russell, A.-M., Murphy, E., Johnston, S. L., Schwartz, D. A., Wells, A. U., Cookson, W. O. C., Maher, T. M., & Moffatt, M. F.
Affiliations
  • National Heart and Lung Institute, Imperial College, London, United Kingdom
  • Imperial College London (GB)
  • National Health Service (GB)
  • National Institute for Health and Care Research (GB)
  • University of Colorado Denver (US)
Corresponding author
Cookson, William O. C.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2014-10-01
Volume
190
Issue
8
Pages
906-913
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2103221430
Cited by
567
References
43
Citations by year
2026: 34 · 2025: 45 · 2024: 51 · 2023: 30 · 2022: 52 · 2021: 60 · 2020: 60 · 2019: 38 · 2018: 46 · 2017: 63 · 2016: 44 · 2015: 37 · 2014: 3
FWCI
39.24
Type
journal article
Language
en
Open access
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
  • Spiral (Imperial College London) (submittedVersion)
Funders
  • Pfizer
  • GlaxoSmithKline
  • Wellcome Trust (097117, G0600879, 096964/Z/11/Z)
  • Royal Brompton and Harefield NHS Foundation Trust
  • National Institute for Health and Care Research (CL-2008-21-014)
  • Imperial College London
  • National Institutes of Health (HL092870)
  • Pfizer UK
  • Medical Research Council (G0600879)
  • National Heart, Lung, and Blood Institute (R01HL097163, HL092870, R33HL120770, P01HL092870, HL097163)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
Keywords
idiopathic pulmonary fibrosis, bacterial load, bronchoalveolar lavage, lung microbiome, 16S rRNA gene sequencing, Haemophilus, Streptococcus, Neisseria, Veillonella, lung function decline, mortality risk, antimicrobial therapy, host susceptibility
MeSH terms
Aged, Bacteria, Bronchoalveolar Lavage Fluid, Bronchoscopy, DNA, Bacterial, Female, Genetic Markers, Humans, Male, Middle Aged, Polymorphism, Genetic, Prospective Studies, Logistic Models, Case-Control Studies, Polymerase Chain Reaction, Sequence Analysis, DNA, Disease Progression, Bronchoalveolar Lavage, Idiopathic Pulmonary Fibrosis, Mucin-5B, Bacterial Load, Genotyping Techniques, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Role of Bacteria in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis. https://app.cochat.ai/papers/10.1164/rccm.201403-0541oc
The paper
Molyneaux, P. L., Cox, M. J., Willis-Owen, S. A. G., Mallia, P., Russell, K. E., Russell, A.-M., Murphy, E., Johnston, S. L., Schwartz, D. A., Wells, A. U., Cookson, W. O. C., Maher, T. M., & Moffatt, M. F. (2014). The Role of Bacteria in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201403-0541oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.